Director of R&D Finance
Overview:
Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it. We imagine a world where cancer is a curable disease.
At Replimune, we live by our values:
United: We Collaborate for a Common Goal.Audacious: We Are Bold and Innovative.
Dedicated: We Give Our Full Commitment.
Candid: We Are Honest With Each Other.
People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, an innovative and collaborative culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to contribute to the meaningful work we do which could impact the lives of patients.
Join us, as we reshape the future.
Job Summary:
The Associate Dir/Director of R&D Finance is a key member of Replimune’s Finance Business Partner team, working with business leaders across the organization. This role will provide financial leadership to all of the company’s R&D departments and it will play a key role in managing the financial aspects of the company’s clinical trials.
This position is based in our Woburn office and welcomes hybrid work! Local candidates are expected to be on-site 2 days per week.
Responsibilities:
- Provide finance leadership and support to the R&D organization and Medical Affairs. Partner closely with stakeholders across the business (including senior leadership) on major recurring deliverables (budgets, forecasts, long range plan, variance analysis, etc.).
- Provide leadership, collaboration, and input into the development and usage of internal dashboards and metrics that help the leadership team monitor important KPIs, business drivers, and trends related to clinical trial spend.
- In support of accounting and clinical outsourcing teams review all clinical site contract costs for monthly accrual and site invoice payment reporting accuracy and forecasting.
- Develop, in close partnership with program team leadership, strategic financial materials to support key internal governance discussions with executive leadership.
- Develop and maintain tools and processes that can support the group’s current needs while also being able to scale for future growth.
- Maintain and improve accuracy of detailed forecast models for multiple existing and future clinical trials.
- Monitor clinical trial actual vs. forecast spend on an ongoing basis and partner with trial leads to explain discrepancies and adjust models appropriately.
- Liaise with R&D cost center business leads to review monthly finance reports, identify and communicate any material risks and/or opportunities, and discuss/research budget line-item variances.
- Support the growth and development of more junior team members (including direct reports).
Qualifications:
Education:
- Bachelor’s Degree in Finance or other degrees with quantitative focus (e.g. Statistics, Econometrics, Mathematics) required, Master's Degree in business and business insights (e.g. MBA) preferred.
Required Experience:
- 10+ years work experience in a combination of FP&A, accounting, valuation and/or other strategic finance roles
- 4+ years of work experience in biotech / pharma industry, R&D experience required
- Must have strong working knowledge of key drivers of clinical trial costs and have experience forecasting trial expenses in close partnership with internal and external stakeholders. Experience supporting trials across various phases of development and therapeutic areas preferred.
- Demonstrated ability to pivot between high-level strategic discussions and operationally executing on deliverables
- Excellent interpersonal skills and ability to work effectively with multiple functions and with stakeholders of various levels of seniority
- Proven ability to work with a high level of integrity, accuracy, and attention to detail
- Maintain a positive, flexible, client-service attitude with business teams
- Passion for excellence
About Replimune
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response.The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response.
The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.
We are an Equal Opportunity Employer.
#LI-Hybrid